Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Neoplastic Cells, Circulating × Neoadjuvant Therapy × Clear all

Status

Unknown 1 Recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Breast Neoplasms 14 Esophageal Squamous Cell Carcinoma 5 Rectal Neoplasms 4 Neoplasms 3 Colorectal Neoplasms 3 Carcinoma, Non-Small-Cell Lung 3 Carcinoma, Hepatocellular 3 Uterine Cervical Neoplasms 2 Stomach Neoplasms 2 Sarcoma 2 Ovarian Neoplasms 2 Nasopharyngeal Carcinoma 2 Lung Neoplasms 2 Urinary Bladder Neoplasms 1 Turcot syndrome 1 Surgery 1 Squamous Cell Carcinoma of External Auditory Canal 1 Recurrence 1 Peritoneal Neoplasms 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Pancreatic Neoplasms 1 Pancreatic Ductal Adenocarcinoma 1 Neoplastic Cells, Circulating 1 Neoadjuvant Therapy 1 Multiple Myeloma 1 Margins of Excision 1 Malignant Tumor of Lacrimal Drainage Structure 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large B-Cell, Diffuse 1 Locally Advanced Rectal Cancer (LARC) 1

Interventions

Blood Specimen Collection 5 Liquid Biopsy 2 Folfox protocol 2 pertuzumab 1 Trastuzumab 1 Surgical Procedures, Operative 1 Standard of Care 1 Sevoflurane 1 Radiotherapy, Adjuvant 1 Propofol 1 Positron Emission Tomography Computed Tomography 1 Neoadjuvant Therapy 1 Mastectomy, Segmental 1 Gemcitabine 1 Fluorouracil 1 Docetaxel 1 Cisplatin 1 Chemotherapy, Adjuvant 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04902937 2023-11-28

CETC

University of Jena

Neoplastic Cells, Circulating

Data powered by HemOnc (CC BY 4.0) Colophon ⚡